Tweet
DIRECTOR OF A. MNJOYAN INSTITUTE OF FINE ORGANIC CHEMISTRY: GOVERNMENT MUST STIMULATE PRODUCTION OF DRUG SUBSTANCES IN ARMENIA
arminfo
Tuesday, December 4, 12:52
A. Mnjoyan Institute of Fine Organic Chemistry (IFOC) has launched
development of several drug substances for local pharmaceutical
enterprises. Director of the Institute of Fine Organic Chemistry,
Scientific-Technological Center of Organic and Pharmaceutical
Chemistry, Armenian National Academy of Sciences, Doctor of Science,
Chemistry, Professor Vigen Topuzyan made such statement to ArmInfo.
He said that the local pharmaceutical enterprises produces medical
preparations using imported substances, while the Institute is able
to launch such production independently. In addition, fine chemicals
can be stored for dozens of years, while substances like medical
preparations have expiry date. The Institute needs government's
investments to create raw materials base. The Institute has 20-25
promising fine chemicals that need pre-clinical and clinical testing,
which requires solid financing, he said.
Topuzyan said that A. Mnjoyan's IFOC cannot work at full capacity
because the government allocates only 200 million drams (nearly
$500,000) annually to the Scientific-Technological Center of Organic
and Pharmaceutical Chemistry, Armenian National Academy of Sciences,
with 70% of the government financing being salary costs. 260-270 out
of 310 employees at the Center are research fellows. IFOC and other
institutes of the Center, such as the Molecular Composition Research
Center and Organic Chemistry Center, have many ideas in applied and
fundamental sciences that can bring significant results, Topuzyan said.
At the same time, the production unit at IFOC issues medical
preparations Gangleronum (registered in Armenia Ukraine, Georgia,
registration process launched in Russia), Dithylin (registered in
Armenia, Ukraine and Belarus) and Tiodin (registered in Armenia).
Puphemidum will be introduced in the Russian market shortly. A new
medical preparation used in case of burns and a complex substance
for treatment of some diseases of the nervous system is currently
being prepared.
Topuzyan said that it took 7 months to produce enough drugs to satisfy
demand in the market in 2011. In the remaining period of time the
production unit was engaged in development of drug substances. He said
that in 2011 the production volumes at IFOC totaled nearly 80 million
drams (some $200,000), while in 2010 the annual production fell to 50
million drams due to low demand and the financial crisis. At present,
IFOC has achieved last year's indicator and envisages production of
substances for another 15 million drams for the Ukrainian market.
Director of A. Mnjoyan IFOC said that they are open for reasonable
investment offers and against the "investors pursuing appropriation
of the institute's assets in the spirit of the privatization of
the mid-90s."
A. Mnjoyan Institute of Fine Organic Chemistry of the
Scientific-Technological Center of Organic and Pharmaceutical
Chemistry, Armenian National Academy of Sciences, was founded in
1955 and was one of the leading center of Soviet pharmacology and
pharmaceutics. The Institute was founded by the efforts of academician
Armenak Mnjoyan. In early 90s, the Institute's financing was suspended
and the markets were lost. Nevertheless, over the last 5 years the
scientists of the Center public 520 research works in the research
magazines in Russia, Europe and USA.
arminfo
Tuesday, December 4, 12:52
A. Mnjoyan Institute of Fine Organic Chemistry (IFOC) has launched
development of several drug substances for local pharmaceutical
enterprises. Director of the Institute of Fine Organic Chemistry,
Scientific-Technological Center of Organic and Pharmaceutical
Chemistry, Armenian National Academy of Sciences, Doctor of Science,
Chemistry, Professor Vigen Topuzyan made such statement to ArmInfo.
He said that the local pharmaceutical enterprises produces medical
preparations using imported substances, while the Institute is able
to launch such production independently. In addition, fine chemicals
can be stored for dozens of years, while substances like medical
preparations have expiry date. The Institute needs government's
investments to create raw materials base. The Institute has 20-25
promising fine chemicals that need pre-clinical and clinical testing,
which requires solid financing, he said.
Topuzyan said that A. Mnjoyan's IFOC cannot work at full capacity
because the government allocates only 200 million drams (nearly
$500,000) annually to the Scientific-Technological Center of Organic
and Pharmaceutical Chemistry, Armenian National Academy of Sciences,
with 70% of the government financing being salary costs. 260-270 out
of 310 employees at the Center are research fellows. IFOC and other
institutes of the Center, such as the Molecular Composition Research
Center and Organic Chemistry Center, have many ideas in applied and
fundamental sciences that can bring significant results, Topuzyan said.
At the same time, the production unit at IFOC issues medical
preparations Gangleronum (registered in Armenia Ukraine, Georgia,
registration process launched in Russia), Dithylin (registered in
Armenia, Ukraine and Belarus) and Tiodin (registered in Armenia).
Puphemidum will be introduced in the Russian market shortly. A new
medical preparation used in case of burns and a complex substance
for treatment of some diseases of the nervous system is currently
being prepared.
Topuzyan said that it took 7 months to produce enough drugs to satisfy
demand in the market in 2011. In the remaining period of time the
production unit was engaged in development of drug substances. He said
that in 2011 the production volumes at IFOC totaled nearly 80 million
drams (some $200,000), while in 2010 the annual production fell to 50
million drams due to low demand and the financial crisis. At present,
IFOC has achieved last year's indicator and envisages production of
substances for another 15 million drams for the Ukrainian market.
Director of A. Mnjoyan IFOC said that they are open for reasonable
investment offers and against the "investors pursuing appropriation
of the institute's assets in the spirit of the privatization of
the mid-90s."
A. Mnjoyan Institute of Fine Organic Chemistry of the
Scientific-Technological Center of Organic and Pharmaceutical
Chemistry, Armenian National Academy of Sciences, was founded in
1955 and was one of the leading center of Soviet pharmacology and
pharmaceutics. The Institute was founded by the efforts of academician
Armenak Mnjoyan. In early 90s, the Institute's financing was suspended
and the markets were lost. Nevertheless, over the last 5 years the
scientists of the Center public 520 research works in the research
magazines in Russia, Europe and USA.